Trexquant Investment LP Celcuity Inc. Transaction History
Trexquant Investment LP
- $8.01 Billion
- Q1 2025
A detailed history of Trexquant Investment LP transactions in Celcuity Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 26,920 shares of CELC stock, worth $352,652. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,920
Previous 11,640
131.27%
Holding current value
$352,652
Previous $152,000
78.95%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CELC
# of Institutions
98Shares Held
30.6MCall Options Held
16.2KPut Options Held
51.9K-
Baker Bros. Advisors LP New York, NY4.26MShares$55.8 Million0.51% of portfolio
-
Bvf Inc San Francisco, CA3.47MShares$45.4 Million1.54% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.57MShares$33.7 Million2.15% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$30.9 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$21.9 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $196M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...